Jan 11, 2024 / 01:15AM GMT
Unidentified Participant
Good afternoon, everyone, and thank you for joining us here today. It is my pleasure to introduce Mike Rossi, President and CEO of Y-mAbs, who will be leading the presentation today; and Bo Kruse, CFO, will be joining Mike in the Q&A.
With that, I'll hand it over to Mike. Thank you, Mike, for joining us here today and sharing your story with us.
Michael Rossi - Y-mAbs Therapeutics Inc - President, Chief Executive Officer, Director
Thank you very much, and welcome to everyone. Thank you very much for attending our presentation of Y-mAbs Technologies -- Y-mAbs Therapeutics, excuse me. My name is Mike Rossi originally joined in November as the President of CEO. So I'm looking forward to taking you through our novel pre-targeted radiopharmaceutical platform, as well as our antibody-based therapy, DANYELZA. So thank you for attending.
As a disclaimer, please note that any of the forward-looking statements may be made today during our presentation and our disclaimer is available on our Investor Relations website.
So Y
Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers